ArticleCellular oncology (Dordrecht, Netherlands)2017

MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.

Han Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.